COVID-19 Lockdown Exit Analysis

Subscribe
Get in touch

Before you go we'd just like to ask you a quick question!

Your vote has been counted in the results below.

If you could vote on Brexit now which option would you choose?
Remain Leave

EMA evaluating Skycovion COVID-19 vaccine

EMA has begun its review of the conditional marketing authorization application from South Korean developer, SK biosciences, for its COVID-19 vaccine, Skycovion, a recombinant protein-based vaccine with adjuvant from GSK. The evaluation of data for ...

BioPharma-Reporter - August 23, 2022

View the full story here: https://www.biopharma-reporter.com/Article/2022/08/22/ema-evaluating-skycovion-covid-19-vaccine?aca_news_section=Global+Industry+News

Contact Us

lockdown_exit@nfind.uk
Our contact form
Curator login

Quick Links

Privacy policy
Terms & Conditions
Cookie Policies

© lockdown_exit 2026. All Right Reserved

Keep up to date with COVID-19 Lockdown Exit Analysis

Name*

Email*

Region*

Enter your region from the drop-down menu so we can tailor the news to you.

Privacy Policy | Terms & Conditions | Cookie Policies

Select or add an image to the Image library

Show only large

Search image library using the following tags

Cookie Notice - News Finder - lockdown_exit

We use cookies to enhance your visit to our site.
Read our Privacy policy, Cookie Policies and Terms & Conditions to find out more.